AKR1C1 and neoplasm: To analyze AKR1C1 protein expression in these ten pairs of ECC patient samples by immunoblotting (IB) assay, we found that there was elevated expression of AKR1C1 in the majority of human ECC specimens (8 cases/10 cases, 80%), compared with matched non-tumor tissues (Fig. 1F).